Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026)
Insmed (INSM) posted quarterly Change in Acquisitions & Divestments of $284.0 million for Q1 2026, down 60.61% year-over-year from $721.0 million in Q1 2025, and down 36.32% quarter-over-quarter from $446.0 million in Q4 2025.
Insmed (INSM) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Insmed's Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $284.0 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 60.61% year-over-year to $284.0 million; the TTM figure through Mar 2026 stood at $1.7 billion (up 15.73% YoY), while the FY2025 annual figure was $2.1 billion, up 106.69% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $284.0 million, down from $446.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $721.0 million in Q1 2025, with the low at $10.0 million in Q3 2023.
- The 5-year median for Change in Acquisitions & Divestments is $300.0 million (2023), against an average of $296.2 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 1100.0% in 2023, while the deepest fall reached 80.0% in 2023.
- Insmed's Change in Acquisitions & Divestments stood at $25.0 million in 2022, then soared by 1100.0% to $300.0 million in 2023, then surged by 138.67% to $716.0 million in 2024, then slumped by 37.71% to $446.0 million in 2025, then sank by 36.32% to $284.0 million in 2026.
- Business Quant data shows INSM's Change in Acquisitions & Divestments at $284.0 million in Q1 2026, $446.0 million in Q4 2025, and $425.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 430.00 Mn |
| Jun 30, 2026 | 430.00 Mn |
| Mar 31, 2026 | 284.00 Mn |
| Mar 31, 2026 | 284.00 Mn |
| Dec 31, 2025 | 446.00 Mn |
| Dec 31, 2025 | 446.00 Mn |
| Sep 30, 2025 | 425.00 Mn |
| Sep 30, 2025 | 425.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Jun 30, 2025 | 508.00 Mn |
| Mar 31, 2025 | 721.00 Mn |
| Mar 31, 2025 | 721.00 Mn |
| Dec 31, 2024 | 716.00 Mn |
| Dec 31, 2024 | 716.00 Mn |
| Mar 31, 2024 | 300.00 Mn |
| Mar 31, 2024 | 300.00 Mn |
| Dec 31, 2023 | 300.00 Mn |
| Dec 31, 2023 | 300.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.00 Mn |